A detailed history of Black Rock Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Black Rock Inc. holds 13,277,637 shares of SGMO stock, worth $5.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,277,637
Previous 14,095,865 5.8%
Holding current value
$5.97 Million
Previous $7.61 Million 16.88%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.42 - $1.38 $343,655 - $1.13 Million
-818,228 Reduced 5.8%
13,277,637 $8.9 Million
Q4 2023

Feb 13, 2024

SELL
$0.3 - $0.63 $510,327 - $1.07 Million
-1,701,091 Reduced 10.77%
14,095,865 $7.61 Million
Q3 2023

Nov 13, 2023

SELL
$0.58 - $1.47 $53,371 - $135,269
-92,020 Reduced 0.58%
15,796,956 $9.48 Million
Q2 2023

Aug 11, 2023

BUY
$1.11 - $1.74 $53,593 - $84,010
48,282 Added 0.3%
15,888,976 $20.7 Million
Q1 2023

May 12, 2023

BUY
$1.66 - $3.67 $798,879 - $1.77 Million
481,253 Added 3.13%
15,840,694 $27.9 Million
Q4 2022

Feb 13, 2023

BUY
$2.77 - $5.07 $3.03 Million - $5.55 Million
1,094,983 Added 7.68%
15,359,441 $48.2 Million
Q3 2022

Nov 14, 2022

BUY
$4.27 - $6.39 $8.11 Million - $12.1 Million
1,898,292 Added 15.35%
14,264,458 $69.9 Million
Q2 2022

Aug 12, 2022

BUY
$3.28 - $6.21 $2.46 Million - $4.66 Million
751,070 Added 6.47%
12,366,166 $51.2 Million
Q1 2022

May 12, 2022

SELL
$5.23 - $7.82 $249,910 - $373,670
-47,784 Reduced 0.41%
11,615,096 $67.5 Million
Q4 2021

Feb 10, 2022

BUY
$7.29 - $10.97 $2.72 Million - $4.09 Million
372,615 Added 3.3%
11,662,880 $87.5 Million
Q3 2021

Nov 09, 2021

BUY
$9.01 - $12.01 $13.6 Million - $18.1 Million
1,506,297 Added 15.4%
11,290,265 $102 Million
Q2 2021

Aug 11, 2021

BUY
$10.17 - $12.64 $99.5 Million - $124 Million
9,783,968 New
9,783,968 $117 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $70.4M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.